461
Participants
Start Date
January 31, 2008
Primary Completion Date
April 30, 2012
Study Completion Date
October 31, 2012
Atacicept 75 mg
75 milligram (mg) atacicept injection will be administered subcutaneously twice weekly during initial loading period for 4 weeks followed by once weekly during maintenance period for subsequent 48 weeks.
Atacicept 150 mg
150 mg atacicept injection will be administered subcutaneously twice weekly during initial loading period for 4 weeks followed by once weekly during maintenance period for subsequent 48 weeks.
Placebo Comparator
Placebo matched to atacicept injection will be administered subcutaneously twice weekly during initial loading period for 4 weeks followed by once weekly during maintenance period for subsequent 48 weeks.
Hospital for Special Surgey, New York
Feinstein Institute for Medical Research, Manhasset
Wayne State University, Detroit
Justus J. Fiechtner, MD, MPH, Lansing
Division of Clinical Immunology and Rheumatology - UAB, Birmingham
Stanford University, Palo Alto
Research Site, San Diego
Inland Rheumatology Clinical Trials Inc, Upland
Research Site, Jacksonville
Research Site, Boise
SUNY Health Science Center at Brooklyn, Brooklyn
Research Site, New York
Research Site, Cincinnati
University of Cincinnati Medical Center, Division of Immunology, Cincinnati
Research Site, Temple
Virginia Mason Medical Center, Seattle
Research Site, Buenos Aires
Research Site, Córdoba
Research Site, Quilmes
Research Site, San Juan
Research Site, San Miguel de Tucumán
Research Site, Cairns
Research Site, Clayton, Victoria
Research Site, Sunshine Coast, Queensland
Research Site, Woodville S.A.
Research Site, Wein
Research Site, Sofia
Research Site, Osijek
Research Site, Rijeka
Research Site, Split
Research Site, Zagreb
Research Site, Prague
Research Site, Bordeaux Pessac
Research Site, Lille
Research Site, Montpelier Cedex
Research Site, Paris
Research Site, Strasbourg
Research Site, Toulouse
Research Site, Berlin
Research Site, Erlangen
Research Site, Hanover
Research Site, Heidelberg
Research Site, Herne
Research Site, München
Research Site, Münster
Research Site, Athens
Research Site, Thessaloniki
Research Site, Secunderabad, Andhra Pradesh
Research Site, Haifa
Research Site, Jerasalem
Research Site, Petah Tikva
Research Site, Tel Aviv
Research Site, Riga
Research Site, Beirut
Research Site, Kaunas
Research Site, Vilnius
Research Site, Kuala Lumpur
Research Site, Perak
Research Site, Seremban
Research Site, Guadalajara Jalisco
Research Site, Tijuana, BC
Research Site, Amsterdam
Research Site, Leiden
Research Site, Maastricht
Research Site, Angeles City
Research Site, Davao City
Research Site, Iloilo City
Research Site, Las Piñas
Research Site, Manila
Research Site, Bialystok
Research Site, Gdansk
Research Site, Krakow
Research Site, Lublin
Research Site, Szczecin
Research Site, Torun
Research Site, Warsaw
Research Site, Kemerovo
Research Site, Petrozavodsk
Research Site, Ryazan
Research Site, Saint Petersburg
Research Site, Saratov
Research Site, Tula
Research Site, Yaroslavl
Research Site, Belgrade
Research Site, New Belgrade
Research Site, Niška Banja
Research Site, Cape Town
Research Site, Durban
Research Site, Panorama, Western Cape
Research Site, Parlow, Western Cape
Research Site, Pinelands
Research Site, Stellenbosch, Western Cape
Research Site, Gyeonggi-do
Research Site, Seoul
Research Site, Barcelona
Research Site, Madrid
Research Site, Málaga
Research Site, Santiago de Compostela
Research Site, Sankt Gallen
Research Site, Taichung
Research Site, Taipei
Research Site, Taoyuan District
Research Site, Donetsk
Research Site, Kharkiv
Research Site, Kyiv
Research Site, Lviv
Research Site, Ternopil
Research Site, Vinnytsia
Research Site, Zhytomyr
Research Site, London
Research Site, Manchester
Brigham and Women's Hospital, Boston
US Local Medical Information, Rockland
Lead Sponsor
Merck KGaA, Darmstadt, Germany
INDUSTRY
EMD Serono
INDUSTRY